- Home
- Personal stories
Personal stories
Health: the next frontier for impact investing
Health-related impact investments remain limited, even as the field now totals a $715 billion global market. J&J Impact Ventures, an investment fund within the J&J Foundation, is investing in purpose-driven entrepreneurs and their startups in the belief that as their businesses grow, so will their impact.
What you need to know about Johnson & Johnson’s 2021 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Devices businesses.
Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.
The next frontier of prostate cancer care
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That’s why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
How your own DNA could someday save your vision
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.
Johnson & Johnson award winner David Julius, Ph.D., receives a 2021 Nobel Prize
The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he’s a Nobel Laureate. Learn about the transformational research that’s led to these well-deserved scientific accolades.
How Johnson & Johnson is supporting the next great leaders in mental health
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for biomedical research
Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
This nurse leader in Liberia is making sure mothers and babies get the healthcare they need
As Liberia country director for Last Mile Health, Marion Subah is working with the Liberia Ministry of Health to scale and sustain the country’s first national community health worker program.